FCER1

FCER1

Diagram of the FcεRI receptor structure.

FCER1 (Fc epsilon receptor I) is a high-affinity IgE receptor that plays a crucial role in allergic reactions and immune system responses. It is primarily found on the surface of mast cells, basophils, and dendritic cells. The interaction between IgE and FCER1 is central to the pathophysiology of allergic diseases such as asthma, allergic rhinitis, and anaphylaxis.

Structure

FCER1 is a tetrameric receptor composed of one alpha (α) chain, one beta (β) chain, and two gamma (γ) chains. The α chain is responsible for binding to the Fc region of IgE, while the β and γ chains are involved in signal transduction.

• Alpha (α) chain: This chain contains the IgE binding site and is crucial for the high-affinity interaction with IgE.
• Beta (β) chain: This chain amplifies the signal transduction initiated by the receptor.
• Gamma (γ) chains: These chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) that are essential for initiating downstream signaling pathways.

Function

The primary function of FCER1 is to mediate the allergic response. Upon binding of IgE to the α chain, the receptor becomes cross-linked by multivalent antigens, leading to the activation of the receptor.

Signal Transduction

Illustration of the IgE FcεRI receptor signal cascade.

The cross-linking of FCER1 by antigen-bound IgE triggers a cascade of intracellular signaling events:

1. Phosphorylation of ITAMs: The γ chains' ITAMs are phosphorylated by Src family kinases, such as Lyn. 2. Activation of Syk kinase: The phosphorylated ITAMs recruit and activate Syk kinase, which further propagates the signal. 3. Downstream signaling: This leads to the activation of multiple signaling pathways, including the MAPK pathway, PI3K pathway, and NF-κB pathway. 4. Degranulation: The signaling culminates in the degranulation of mast cells and basophils, releasing histamine, cytokines, and other mediators of inflammation.

Clinical Significance

FCER1 is a critical component in the development of allergic diseases. The receptor's high affinity for IgE makes it a target for therapeutic interventions aimed at reducing allergic responses. Inhibiting the interaction between IgE and FCER1 can potentially alleviate symptoms of allergic diseases.

Related Pages

• IgE
• Mast cell
• Basophil
• Allergic reaction
• Anaphylaxis